Cosmeceuticals During COVID: New Natural Infusions, Same Regulatory Jungle
The Pandemic, Clean Beauty Demand Drive Innovation At Cosmetic/Drug Borderline
Executive Summary
Consumers with time on their hands at home have become better researched about plant-derived ingredients that deliver results, which, according to Lodaat Pharmaceuticals, is where cosmeceuticals are headed. Cosmeceutical possibilities and regulatory complexities were the substance of a panel discussion at CPhI Worldwide, featuring Lodaat director Rajiv Khatau and EAS Consulting’s John Bailey.